About Mesoblast

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders.

website icon
Website
employees icon
Employees
industry icon
Industry
Medical Practices
location icon
Headquarter
Melbourne
description icon
Founded
2004

Mesoblast Alternatives

Industry
Health Care
Industry
Health Care
Industry
Health Care
Industry
Health Care

Frequently Asked Questions about Mesoblast

Who are the decision makers in Mesoblast?

The decision makers in Mesoblast are Adrienne W, Alain Vertes, Michael Dimuro, etc. Click to Find Mesoblast decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more